FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells

Titel:: FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Sperk, Anna; Gabriel, Antje; Koch, Daniela; Augsburger, Abirami; Sanchez, Victoria; Brockelt, David; Öllinger, Rupert; Engleitner, Thomas; Giansanti, Piero; Ludwig, Romina; Auf der Maur, Priska; Walter, Wencke; Haferlach, Torsten; Jeremias, Irmela; Rad, Roland; Steigenberger, Barbara; Kuster, Bernhard; Eichner, Ruth; Bassermann, Florian
Zeitschriftentitel:: Leukemia
Jahr:: 2024
Volltext / DOI:: doi:10.1038/s41375-024-02345-0
Verlag / Institution:: Springer Science and Business Media LLC
E-ISSN:: 0887-69241476-5551
Publikationsdatum:: 16.07.2024
BibTeX

Vorkommen: